Nath Bio-Genes (India) Ltd (BOM:537291)
₹ 186.7 1.8 (0.97%) Market Cap: 3.51 Bil Enterprise Value: 2.85 Bil PE Ratio: 9.06 PB Ratio: 0.56 GF Score: 62/100

Q4 2024 Nath Bio-Genes (I) Ltd Earnings Call Transcript

May 09, 2024 / 10:30AM GMT
Release Date Price: ₹193.7 (-5.19%)
Operator

Ladies and gentlemen, good day, and welcome to the Q4 FY24 earnings conference call of Nath Bio-Genes, hosted by Go India Advisors. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Deepika Sharma from Go India Advisors. Thank you and over to you, ma'am.

Deepika Sharma;Satish Kagliwal
Go India Advisors - Investor Relations

Thank you, Mukhan. Good afternoon, everyone, and welcome to the Q4 FY24 earnings call of Nath Bio-Genes Limited. We have on the call Mr. Satish Kagliwal, Managing Director; Mr. Devinder Khurana, Chief Financial Officer; Mr. Harish Pandey, Business Lead; Dr. Venkatesh Kulkarni, Research Lead. We must remind you that the discussion on today's call may include certain forward-looking statements and must be therefore viewed in conjunction with the risk that company faces.

May I now request the management to take us through the financials and the business outlook subsequent to which we will open the floor for Q&A. Thank you, and over to you, sir.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot